Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

@article{Ohlsson2014EarlyEF,
  title={Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.},
  author={Arne Ohlsson and Sanjay M Aher},
  journal={The Cochrane database of systematic reviews},
  year={2014},
  volume={4},
  pages={CD004863}
}
BACKGROUND Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anaemia. OBJECTIVES To assess the effectiveness and safety of early initiation of EPO or darepoetin (initiated before eight days after birth) in reducing red blood cell (RBC) transfusions in preterm and/orlow birth weight infants. SEARCH METHODS The Cochrane Library, MEDLINE, EMBASE, CINAHL, reference lists of identified trials and reviews, Pediatric Academic… CONTINUE READING
0 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…